Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Peripheral Blood Progenitor Cells
100%
High-dose Chemotherapy
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
81%
Leukapheresis
75%
CD34+ Cells
65%
Peripheral T-cell Lymphoma
50%
Relapsed or Refractory multiple Myeloma
50%
International Myeloma Working Group
50%
Autologous Stem Cells
50%
Native Valve Infective Endocarditis
50%
Large Volume Leukapheresis
50%
Antibiotic Therapy
50%
Large Volume
50%
Oncologia
50%
Lisboa
50%
Stem Cell Support
50%
Stem Cell Transplantation
50%
Germ Cell Tumor
50%
Immunocompromised Patients
50%
Peripheral Blood
40%
Blood Volume
35%
Infective Endocarditis
33%
Mitral
33%
Cell Separator
25%
PBSC Transplantation
25%
Transplant-related Mortality
25%
Hematotoxicity
25%
Hematopoietic Recovery
25%
Transplantation
25%
Neoplasia
25%
Complete Remission
25%
Clonogenic
25%
CFU-GM
25%
Efficiency Increase
25%
Growth Factors
25%
Cure Rate
25%
Overall Survival
25%
Chemotherapy
25%
Bone Marrow
25%
Two-parameter
25%
Laboratory Methods
25%
Reperfusion
25%
Male Patients
22%
Relapsed Disease
20%
Calcific
16%
Splenectomized
16%
Uncontrolled Infection
16%
Clinical Stability
16%
Clinical Laboratory
16%
Aortic Valve Disease
16%
Medicine and Dentistry
Progenitor Cell
100%
High Dose Chemotherapy
100%
Leukapheresis
75%
Multiple Myeloma
50%
Stem Cell Therapy
50%
Antibiotic Therapy
50%
Infective Endocarditis
50%
Immunocompromised Patient
50%
Myeloma
50%
Stem Cell
50%
Germinoma
50%
Autologous Stem Cell Transplantation
44%
Diseases
34%
Overall Survival
30%
Neoplasm
25%
Infusion
25%
Growth Factor
25%
Colony Forming Unit S
25%
Allogeneic Hematopoietic Stem Cell Transplantation
25%
Infection
16%
Aortic Valve Disease
16%
Congestive Heart Failure
16%
Conservative Approach
16%
Immunosuppressive Treatment
16%
Streptococcus Dysgalactiae
16%
Hodgkin's Lymphoma
16%
Prospective Study
12%
Non-Hodgkin Lymphoma
12%
Allograft
12%
Recurrence Free Survival
12%
Aggressive Lymphoma
12%
Autologous Hematopoietic Stem Cell Transplantation
12%
Hematopoietic Stem Cell Transplantation
12%
Mediastinal Germ Cell Tumor
11%
Autotransplantation
6%
Germ Cell Cancer
5%
Etoposide
5%
Ifosfamide
5%
Progression Free Survival
5%
Therapeutic Modality
5%
Clinical Trial
5%
Testis Tumor
5%
Carboplatin
5%
High Risk Population
5%
Contraindication
5%